Nanollose Ltd (NC6)

Snapshot

NC6's Principal Activity is the research and development, and promotion of the Company's microbial cellulose technology.

Announcements

Corporate Overview

Dividend History

DPS and Yield calculations use the Pay Date.

Directors & Management

Name	Title	Since	Bio
Ms Heidi Beatty	Non-Executive Director	Jul 2019	Ms Heidi Beatty Non-Executive Director Ms Beatty is founder of Crown Abbey Ltd and has 20 years' experience developing consumer and health care products. Heidi worked with Johnson & Johnson for 10 years in Europe and the US. In 2015 Heidi founded Crown Abbey Ltd.
Mr Terence (Terry) Walsh	Non-Executive Director	Aug 2016	Mr Terence (Terry) Walsh Non-Executive Director Mr Walsh has more than 20 years of experience in project development, mining and general commercial law. He initially worked with law firms in Perth and Sydney before moving in house, where he has worked as the General Counsel of Hancock Prospecting Pty Ltd and prior to that as a Corporate Counsel with Rio Tinto Ltd.
Dr Wayne Morris Best	Executive Chairman,Executive Director	Sep 2014	Dr Wayne Morris Best Executive Chairman,Executive Director Dr Best has 36 years' experience in organic chemistry both in academia, government and industry. He then spent two years at Imperial College in the UK where he obtained a DIC, followed by a year at the Australian National University in Canberra. He then took up a position with ICI Australia's Research Group in Melbourne for four and a half years which included a secondment to ICI Agrochemicals' in the UK. Following ICI, Wayne returned to Western Australia and spent ten years at the Chemistry Centre (WA) where he was responsible for the formation and running of the Medicinal & Biological Chemistry Section which undertook collaborative R&D into drug discovery and contract synthesis for the drug discovery and pharmaceutical industries. He then founded Epichem Pty Ltd which he managed for 14 years before moving to Nanollose. He is currently Epichem's non-executive chairman. He has served as a Director for several listed and unlisted biotechnology companies.
Mr Winton William Willesee	Non-Executive Director	Sep 2014	Mr Winton William Willesee Non-Executive Director Mr Willesee is an experienced corporate professional with experience in strategy, company development, corporate governance, company public listings, merger and acquisition transactions and corporate finance. Mr Willesee has experience with ASX listed and other companies over a range of industries, having held directorships, chairmanships and company secretarial positions with a number of ASX-listed companies over many years.
Ms Erlyn Dale	Company Secretary	N/A

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
14/01/21	Winton Willesee	Buy	+170,000	$0.083	$14,110	On-market trade
04/12/20	Raffaele (Alfie) Germano	Issued	2,000,000	$0.049	$98,000	Director remuneration
04/12/20	Raffaele (Alfie) Germano	Issued	146,796	$0.026	$3,750	Director remuneration
04/12/20	Raffaele (Alfie) Germano	Issued	500,000	$0.049	$24,500	Conversion of securities
04/12/20	Raffaele (Alfie) Germano	Exercise	500,000	$0.049	$24,500	Conversion of securities
04/12/20	Terence (Terry) Walsh	Issued	68,504	$0.026	$1,750	Director remuneration
04/12/20	Winton Willesee	Issued	68,504	$0.026	$1,750	Director remuneration
04/12/20	Heidi Beatty	Issued	500,000	$0.049	$24,500	Director remuneration
04/12/20	Heidi Beatty	Issued	68,504	$0.026	$1,750	Director remuneration
04/12/20	Wayne Best	Issued	2,000,000	$0.049	$98,000	Director remuneration
04/12/20	Wayne Best	Issued	146,796	$0.026	$3,750	Director remuneration
13/05/20	Winton Willesee	Issued	2,237,143	$0.024	$53,691	Rights issue
13/05/20	Wayne Best	Issued	2,367,144	$0.024	$56,811	Rights issue
13/05/20	Terence (Terry) Walsh	Issued	200,000	$0.024	$4,800	Rights issue
13/05/20	Raffaele (Alfie) Germano	Issued	200,000	$0.024	$4,800	Rights issue
20/11/19	Wayne Best	Issued	2,000,000	$0.071	$142,000	Issue of securities
20/11/19	Raffaele (Alfie) Germano	Issued	2,000,000	$0.071	$142,000	Issue of securities
02/05/19	Wayne Best	Buy	+100,000	$0.063	$6,320	On-market trade
04/12/18	Wayne Best	Buy	+100,000	$0.097	$9,700	On-market trade

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Winton Willesee	14/01/2021	N/A	8,068,504	2,688,691	N/A
Heidi Beatty	04/12/2020	68,504	N/A	500,000	N/A
Terence (Terry) Walsh	04/12/2020	700,000	68,504	1,625,000	N/A
Wayne Best	04/12/2020	0	8,431,798	2,694,941	N/A

Show All

Top 20 Shareholders

About the Data

Name	Shares	Capital
Wayne Morris Best	8,285,002	7.83%
Azalea Family Holdings Pty Ltd	7,830,000	7.40%
Stonehorse Nominees Pty Ltd	6,351,190	6.01%
John Moursounidis	5,934,523	5.61%
Mrs Suzanne Margaret Cass	4,870,285	4.61%
Kohen Enterprises Ny Ltd	3,008,001	2.84%
Mr Adam Laurence Bode	2,500,000	2.36%
Tripit Pty Ltd	2,500,000	2.36%
Jaek Holdings Pty Ltd	2,200,000	2.08%
Mr Michael Francis Mcmahon & Mrs Susan Lesley Mcmahon	2,070,000	1.96%
Mr Michael Hilton Holbrook	1,515,433	1.43%
Mr Stephen Gordon Pattrick	1,150,000	1.09%
Fano Pty Ltd	1,120,000	1.06%
Mr John Oakley Clinton & Mrs Lilian Achieng Clinton	1,063,683	1.01%
Xeen Pty Ltd	1,057,251	1.00%
Dr Richard Galluzzo & Ms Tanya Mccarthy	1,032,955	0.98%
Asmac Investments Pty Ltd	1,003,843	0.95%
Mr Graham Arthur Robinson	1,000,000	0.95%
Mr John William Matthews	1,000,000	0.95%
Vageli Panagiotidis	1,000,000	0.95%
Park And Mayfair Pty Ltd	1,000,000	0.95%
Apam Holdings Pty Ltd	966,666	0.91%
Mr Peter Howells	927,500	0.88%
Gfa Services Pty Ltd	857,519	0.81%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
2020	$0.04	30 June
2019	$0.047	28 June
2018	$0.13	29 June

NC6 Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.